Alembic Pharmaceuticals Limited (NSE: APLLTD)
India flag India · Delayed Price · Currency is INR
1,035.45
-9.75 (-0.93%)
Dec 24, 2024, 3:30 PM IST

Alembic Pharmaceuticals Revenue

Alembic Pharmaceuticals had revenue of 16.48B INR in the quarter ending September 30, 2024, with 3.33% growth. This brings the company's revenue in the last twelve months to 63.57B, up 6.02% year-over-year. In the fiscal year ending March 31, 2024, Alembic Pharmaceuticals had annual revenue of 62.29B with 10.19% growth.

Revenue (ttm)
63.57B
Revenue Growth
+6.02%
P/S Ratio
3.20
Revenue / Employee
4.28M
Employees
14,858
Market Cap
203.53B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 202462.29B5.76B10.19%
Mar 31, 202356.53B3.47B6.54%
Mar 31, 202253.06B-873.40M-1.62%
Mar 31, 202153.93B7.87B17.10%
Mar 31, 202046.06B6.71B17.06%
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro
Mar 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition